Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial

NCT04069312 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT04069312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04069312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial
Lead sponsor
Johns Hopkins University
Phase
Phase 3
Overall status
Completed
Start date
February 11, 2020
Completion date
March 1, 2026
Enrollment
1,032 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

chronic bronchitis, chronic obstructive pulmonary disease severe